Relugonat 120mg Tablet

About

Relugonat 120mg Tablet contains Relugolix, a novel, non-peptide, orally administered gonadotropin-releasing hormone (GnRH) receptor antagonist. Its mechanism of action involves competitively binding to and blocking GnRH receptors located in the anterior pituitary gland. This blockade effectively inhibits the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary. Consequently, the downstream production of sex hormones, specifically testosterone in men and estrogen in women, is significantly suppressed. This rapid and profound reduction in circulating sex hormone levels makes Relugolix an effective treatment for various hormone-sensitive conditions, including advanced prostate cancer, uterine fibroids, and endometriosis. Its oral bioavailability provides a convenient and less invasive alternative to traditional injectable GnRH agonists, offering a targeted approach to hormonal suppression.

Uses

• Treatment of advanced prostate cancer.
• Management of uterine fibroids.
• Treatment of endometriosis-associated pain.
• Reduction of testosterone levels in men.

Directions For Use

Take this tablet orally once daily, at approximately the same time each day, with or without food.

Benefits

• Effectively lowers sex hormone levels.
• Oral administration offers convenience.
• Rapid onset of action compared to agonists.
• Reduces tumor growth in prostate cancer.
• Alleviates symptoms of uterine fibroids.
• Manages pain associated with endometriosis.

Side Effects

• Hot flashes
• Diarrhea
• Joint pain
• Fatigue
• Nausea
• Headache
• Hair loss
• Decreased libido
• Bone density loss (long-term)
• Anemia
• Weight gain
• Sleep disturbances

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake should be avoided.
• Pregnancy - Contraindicated during pregnancy due to its hormonal effects and potential harm to the fetus.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and affect the infant.
• Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary.
• Kidney - No specific dose adjustment is typically required for mild to moderate kidney impairment.
• Lung - No specific contraindications related to lung conditions; generally considered safe.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.